Notably, gene mutations in the EBV infection response pathway, such as TRAF3 (37), NFKBIA (30), RB1 (38), and PIK3CA (39), have been reported to play an important role during cancer development. The gene discussed is RB1; the disease is Epstein-Barr virus infection.